Fortress Biotech Valuation
| FBIOP Preferred Stock | USD 5.91 0.71 13.65% |
At this time, the firm appears to be undervalued. Fortress Biotech Pref shows a prevailing Real Value of $5.5 per share. The current price of the firm is $5.91. Our model computes the value of Fortress Biotech Pref from reviewing the firm fundamentals such as Shares Outstanding of 56.68 M, profit margin of (1.17) %, and Current Valuation of 2.58 B as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Fortress Biotech's price fluctuation is slightly risky at this time. Calculation of the real value of Fortress Biotech Pref is based on 3 months time horizon. Increasing Fortress Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Fortress Biotech's intrinsic value may or may not be the same as its current market price of 5.91, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.91 | Real 5.5 | Hype 5.2 |
The intrinsic value of Fortress Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fortress Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Fortress Biotech Pref helps investors to forecast how Fortress preferred stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fortress Biotech more accurately as focusing exclusively on Fortress Biotech's fundamentals will not take into account other important factors: Fortress Biotech Total Value Analysis
Fortress Biotech Pref is currently estimated to have takeover price of 2.58 B with market capitalization of 107.79 M, debt of 46.56 M, and cash on hands of 248.77 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Fortress Biotech fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.58 B | 107.79 M | 46.56 M | 248.77 M |
Fortress Biotech Investor Information
The company recorded a loss per share of 0.86. Fortress Biotech Pref last dividend was issued on the 14th of February 2023. Based on the key indicators obtained from Fortress Biotech's historical financial statements, Fortress Biotech Pref is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Fortress Biotech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Fortress Biotech has an asset utilization ratio of 17.35 percent. This connotes that the Company is making $0.17 for each dollar of assets. An increasing asset utilization means that Fortress Biotech Pref is more efficient with each dollar of assets it utilizes for everyday operations.Fortress Biotech Ownership Allocation
Fortress Biotech holds a total of 56.68 Million outstanding shares. Roughly 98.2 percent of Fortress Biotech outstanding shares are held by general public with 1.8 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Fortress Biotech Profitability Analysis
The company reported the revenue of 68.79 M. Net Loss for the year was (164.83 M) with loss before overhead, payroll, taxes, and interest of (85.66 M).Fortress Biotech Past Distributions to stockholders
About Fortress Biotech Valuation
The preferred stock valuation mechanism determines Fortress Biotech's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Fortress Biotech Pref based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fortress Biotech. We calculate exposure to Fortress Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Fortress Biotech's related companies.Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 173 people.
8 Steps to conduct Fortress Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Fortress Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Fortress Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Fortress Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Fortress Biotech's revenue streams: Identify Fortress Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Fortress Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Fortress Biotech's growth potential: Evaluate Fortress Biotech's management, business model, and growth potential.
- Determine Fortress Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Fortress Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of Fortress Biotech represents a small ownership stake in the entity. As a stockholder of Fortress, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Fortress Biotech Dividends Analysis For Valuation
Please note that Fortress Biotech has scaled down on payment of dividends at this time.
There are various types of dividends Fortress Biotech can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Fortress shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Fortress Biotech Pref directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Fortress pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Fortress Biotech by the value of the dividends paid out.
Fortress Biotech Growth Indicators
Investing in growth stocks can be very risky. If the company such as Fortress Biotech does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 66 M | |
| Retained Earnings | -547.5 M | |
| Retained Earnings Total Equity | -547.5 M |
Additional Tools for Fortress Preferred Stock Analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.